{"entity":{"id":"nct06873763","kind":"trial","name":"Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer","aka":[],"tldr":"A phase 1/2 trial of Trifluridine/tipiracil, Bevacizumab in colorectal cancer, run by STCube, Inc., now recruiting.","summary":"Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer is a phase 1/2 interventional study registered as NCT06873763 by STCube, Inc., with 52 participants planned, started 2025-06-09 and due to reach its primary completion in 2025-12. Interventions recorded: Nelmastobart 800 mg+Trifluridine/Tipiracil+ Bevacizumab. Conditions listed: Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06873763","url":"https://clinicaltrials.gov/study/NCT06873763"}],"tags":["ctgov-ingest"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":["trifluridine-tipiracil","bevacizumab"],"companies":["stcube"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06873763","phase":"1/2","setting":"A Single-arm, Phase Ib/2 Study of Nelmastobart in Combination With Trifluridine/Tipiracil and Bevacizumab in Metastatic/Recurrent Colorectal Cancer Patients With Resistance or Intolerance to Oxaliplatin and Irinotecan-based Chemotherapy","sponsor":"STCube, Inc.","enrolled":52,"outcomes":[]},"route":"/trials/nct06873763/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"drug":[{"id":"bevacizumab","kind":"drug","name":"Bevacizumab","route":"/drugs/bevacizumab/"},{"id":"trifluridine-tipiracil","kind":"drug","name":"Trifluridine/tipiracil","route":"/drugs/trifluridine-tipiracil/"}],"company":[{"id":"stcube","kind":"company","name":"STCube","route":"/companies/stcube/"}]}}